• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Abeona Therapeutics (NQ: ABEO )

    4.060 -0.110 (-2.64%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 540,587
    Open 4.170
    Bid (Size) 4.010 (8)
    Ask (Size) 4.320 (1)
    Prev. Close 4.170
    Today's Range 4.030 - 4.320
    52wk Range 2.830 - 9.010
    Shares Outstanding 41,186,004
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    ABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q1 2024
    ABEO stock results show that Abeona Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
    From Abeona Therapeutics Inc.
    Via GlobeNewswire

    Performance

    YTD
    -26.58%
    -26.58%
    1 Month
    +28.08%
    +28.08%
    3 Month
    -41.83%
    -41.83%
    6 Month
    -5.80%
    -5.80%
    1 Year
    +26.48%
    +26.48%

    More News

    Read More
    Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    The Law Offices of Frank R. Cruz Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    Crude Oil Moves Higher; General Motors Earnings Top Views
    Via Benzinga
    Exposures Fossil Fuels
    Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Dow Jumps Over 200 Points; US Services PMI Falls In April
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Affirm (AFRM) Stock Moving Today?
    Via InvestorPlace
    US Stocks Higher; PepsiCo Posts Upbeat Earnings
    Via Benzinga
    FDA Rejects Approval Of Abeona Therapeutics' Skin Disorder Treatment, Shares Sink
    Via Benzinga
    Exposures Product Safety
    Why Is Greenwave Technology Solutions (GWAV) Stock Down 47% Today?
    Via InvestorPlace
    Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today?
    Via InvestorPlace
    Exposures Product Safety
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Calix Reports Mixed Results, Joins Cadence Design Systems And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga
    Abeona Therapeutics Provides Regulatory Update on Pz-cel
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    ABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q4 2023
    Via InvestorPlace
    Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.